TENS Trial to Prevent Neuropathic Pain in SCI

Exclusion Criteria

• •More than four months since date of injury;
• •Contraindications for the study intervention, transcutaneous electrical nerve stimulation (TENS),88 including:
• •Implanted electronic device such as a pacemaker;
• •Cardiovascular problems;
• •Pregnancy;
• •Epilepsy;
• •Cancer;
• •Persons with a spinal cord injury at the C2 level, as placement of TENS electrodes on the neck is not recommended;
• •Cognitive dysfunction which limits the ability of the participant to adequately understand procedures and risks.
• •Prisoners
• •Pregnant Women
• •Special populations:
• •Adults unable to consent: excluded from study
• •Individuals -who are not yet adults: individuals who are less than 18 years old will be excluded from the study
• •Pregnant women: Women who are known to be pregnant will not be recruited into the study. A pregnancy test will be administered to females prior to enrollment in TENS (or sham) treatment. Women who become pregnant before or during the 8-week TENS treatment period will be discontinued from the study. Women who become pregnant after the 8-week TENS treatment portion of the study will continue to be enrolled, and followed according to protocol guidelines (no information will be collected specifically on the pregnancy or fetus).
• •Prisoners: excluded from study
• •Neonates: not applicable